0

540937

MEDICO

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

MEDICO REMEDIES LIMITED Share Price Update

As of the latest trading session, MEDICO REMEDIES LIMITED is trading at ₹46.1, down by ₹-1.45 or -3.04% from its previous close. The stock has moved between ₹46.07 and ₹48.17 today. Over the past year, the stock has delivered a return of -10.63%. In the last month, it has returned 12.36%.

Investment Returns

Over 1 Month 12.36% Over 3 Months 11.91% Over 6 Months -9.17% Over 1 Year -10.63%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

MEDICO REMEDIES LIMITED fundamentals


  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield [-]%
  • Net profit/quarter (Cr) [-]
info icon alternate text
  • Market cap (Cr) 389.80
  • P/E Ratio (TTM) 30.09
  • Beta 0.61
  • Book Value / share 9.09
  • Return on equity 17.57%
  • EPS (TTM) 1.58
  • Dividend yield [-]%
  • Net profit/quarter (Cr) 5.86
info icon alternate text

MEDICO REMEDIES LIMITED Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 56.81
Operating Expense 51.36
Net Profit 5.86
Net Profit Margin (%) 10.31
Earnings Per Share (EPS) 0.71
EBITDA 10.02
Effective Tax Rate (%) 29.56
Particulars DEC 2025 (Values in Cr)
Revenue 58.68
Operating Expense 55.53
Net Profit 2.87
Net Profit Margin (%) 4.89
Earnings Per Share (EPS) 0.35
EBITDA 5.01
Effective Tax Rate (%) 25.06
Particulars SEP 2025 (Values in Cr)
Revenue 52.64
Operating Expense 50.89
Net Profit 2.57
Net Profit Margin (%) 4.88
Earnings Per Share (EPS) 0.31
EBITDA 4.43
Effective Tax Rate (%) 26.22
Particulars JUN 2025 (Values in Cr)
Revenue 38.25
Operating Expense 36.47
Net Profit 1.82
Net Profit Margin (%) 4.75
Earnings Per Share (EPS) 0.22
EBITDA 3.48
Effective Tax Rate (%) 25.51
Particulars MAR 2025 (Values in Cr)
Revenue 41.30
Operating Expense 35.89
Net Profit 4.34
Net Profit Margin (%) 10.50
Earnings Per Share (EPS) 0.52
EBITDA 6.96
Effective Tax Rate (%) 23.85
Particulars MAR 2026 (Values in Cr)
Revenue 206.38
Operating Expense 194.25
Net Profit 13.12
Net Profit Margin (%) 6.35
Earnings Per Share (EPS) 1.58
EBITDA 22.95
Effective Tax Rate (%) 27.35
Particulars MAR 2025 (Values in Cr)
Revenue 150.94
Operating Expense 140.13
Net Profit 10.09
Net Profit Margin (%) 6.68
Earnings Per Share (EPS) 1.22
EBITDA 17.69
Effective Tax Rate (%) 25.25
Particulars MAR 2024 (Values in Cr)
Revenue 144.92
Operating Expense 135.70
Net Profit 8.29
Net Profit Margin (%) 5.72
Earnings Per Share (EPS) 1.00
EBITDA 15.03
Effective Tax Rate (%) 26.83
Particulars MAR 2023 (Values in Cr)
Revenue 140.44
Operating Expense 134.29
Net Profit 7.24
Net Profit Margin (%) 5.15
Earnings Per Share (EPS) 0.87
EBITDA 13.57
Effective Tax Rate (%) 28.31
Particulars MAR 2022 (Values in Cr)
Revenue 121.02
Operating Expense 116.56
Net Profit 4.81
Net Profit Margin (%) 3.97
Earnings Per Share (EPS) 2.90
EBITDA 9.36
Effective Tax Rate (%) 25.77
Particulars MAR 2025 (Values in Cr)
Book Value / Share 7.53
ROE % 17.57
ROCE % 21.31
Total Debt to Total Equity 0.20
EBITDA Margin 11.72
Particulars MAR 2024 (Values in Cr)
Book Value / Share 6.31
ROE % 17.23
ROCE % 21.24
Total Debt to Total Equity 0.19
EBITDA Margin 10.37
Particulars MAR 2023 (Values in Cr)
Book Value / Share 5.28
ROE % 18.00
ROCE % 21.01
Total Debt to Total Equity 0.28
EBITDA Margin 9.66
Particulars MAR 2022 (Values in Cr)
Book Value / Share 22.04
ROE % 13.93
ROCE % 14.74
Total Debt to Total Equity 0.40
EBITDA Margin 7.73
Particulars MAR 2021 (Values in Cr)
Book Value / Share 78.22
ROE % 8.31
ROCE % 10.11
Total Debt to Total Equity 0.46
EBITDA Margin 5.12
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 1.09
Total Assets 119.79
Total Liabilities 119.79
Total Equity 62.46
Share Outstanding 8
Price to Book Ratio 6.92
Return on Assets (%) 8.42
Return on Capital (%) 13.23
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.18
Total Assets 96.19
Total Liabilities 96.19
Total Equity 52.37
Share Outstanding 8
Price to Book Ratio 7.81
Return on Assets (%) 8.61
Return on Capital (%) 14.02
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.91
Total Assets 87.44
Total Liabilities 87.44
Total Equity 43.84
Share Outstanding 8
Price to Book Ratio 14.15
Return on Assets (%) 8.28
Return on Capital (%) 13.94
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 2.34
Total Assets 77.40
Total Liabilities 77.40
Total Equity 36.57
Share Outstanding 1
Price to Book Ratio 3.81
Return on Assets (%) 6.21
Return on Capital (%) 10.2
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 2.83
Total Assets 75.62
Total Liabilities 75.62
Total Equity 32.46
Share Outstanding 0
Price to Book Ratio 1.28
Return on Assets (%) 3.42
Return on Capital (%) 5.45
Particulars MAR 2025 (Values in Cr)
Net Income 13.50
Cash from Operations 8.69
Cash from Investing -3.45
Cash from Financing -0.52
Net change in Cash 0.91
Free Cash Flow 8.69
Particulars MAR 2024 (Values in Cr)
Net Income 11.33
Cash from Operations 5.60
Cash from Investing -2.67
Cash from Financing -0.49
Net change in Cash -0.72
Free Cash Flow 5.60
Particulars MAR 2023 (Values in Cr)
Net Income 10.09
Cash from Operations 10.66
Cash from Investing -6.60
Cash from Financing -1.81
Net change in Cash -0.25
Free Cash Flow 10.66
Particulars MAR 2022 (Values in Cr)
Net Income 6.48
Cash from Operations 7.65
Cash from Investing -1.75
Cash from Financing -5.77
Net change in Cash -1.66
Free Cash Flow 7.65
Particulars MAR 2021 (Values in Cr)
Net Income 2.59
Cash from Operations -10.38
Cash from Investing -16.96
Cash from Financing 18.28
Net change in Cash -9.99
Free Cash Flow 6.58
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 35.29 14.58 1.70 270.44 23.12 38.50
BLISS GVS PHARMA LTD. 402.00 32.52 3.56 4252.72 118.35 437.40
CIPLA LTD. 1390.85 27.54 3.26 112352.94 1165.55 1672.20
FERMENTA BIOTECH LIMITED 300.35 13.25 2.17 883.96 256.40 399.00
GLAXOSMITHKLINE PHARMA LT 2203.65 36.57 16.46 37331.16 2184.00 3515.95
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 35.29 24.68 4.54 270.44 23.12 38.50
AMRUTANJAN HEALTH CARE LTD. 558.20 25.02 4.35 1613.79 490.00 789.95
ASTRAZENECA PHARMA INDIA LTD. 8724.25 113.94 24.98 21810.63 7630.00 10653.05
BLISS GVS PHARMA LTD. 402.00 43.23 3.68 4252.72 118.35 437.40

MEDICO REMEDIES LIMITED shareholding pattern

Holding
38.59%
61.38%
0.02%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

News

Left Arrow
Right Arrow

MEDICO REMEDIES LIMITED Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
46.97 -1.21 redarrow
red-green-graph indicator
4 Bearish
12 Bullish
  • 5 Days 47.70
  • 26 Days 44.80
  • 10 Days 47.10
  • 50 Days 43.70
  • 12 Days 46.70
  • 100 Days 44.10
  • 20 Days 45.50
  • 200 Days 45.40
48.75 PIVOT
First Support 46.41 First Resistance 50.04 Second Support 45.12 Second Resistance 52.38 Third Support 42.78 Third Resistance 53.67
RSI 65.73 ADX 39.40 MACD 1.97 Williams % R -51.58 Commodity Channel Index (CCI) 100.99
Date 2026-06-01 Week 19827.00 Same Day 8216.00 Month 10627.00
1 Year 0.62 3 Year 0.48
Over 1 Month
12.36% down
Over 1 Year
-10.63% down
Over 3 Months
11.91% down
Over 3 Years
-18.10% down
Over 6 Months
-9.17% down
Over 5 Years
48.98% down

MEDICO REMEDIES LIMITED Corporate Actions

Ex-Date Ex-Bonus Ratio
17 Nov 2021 16 Nov 2021 3:1
Ex-Date Old FV NEW FV Record Date
16 Mar 2023 10.0 2.0 16 Mar 2023

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Medico Remedies Ltd?

Answer Field

Medico Remedies Ltd share price is for NSE ₹ 46.44 & for BSE ₹ 46.97 as on Jun 03 2026 03:29 PM.

What is the Market Cap of Medico Remedies Ltd Share?

Answer Field

The market cap of Medico Remedies Ltd for NSE ₹ 0.00 & for BSE ₹ 389.80 as on Jun 03 2026 03:29 PM.

What is the 52 Week High and Low of Medico Remedies Ltd?

Answer Field

The 52 Week High and Low of Medico Remedies Ltd for NSE is ₹ 56.88 and ₹ 30.22 and for BSE is ₹ 57.00 and ₹ 31.00.

What is 1 year return for Medico Remedies Ltd?

Answer Field

The 1 year returns on the stock has been -10.93%.

What is the P/E Ratio of Medico Remedies Ltd Share?

Answer Field

As on Jun 03 2026 03:29 PM the price-to-earnings (PE) ratio for Medico Remedies Ltd share is 30.09.

What is the PB ratio of Medico Remedies Ltd Share?

Answer Field

As on Jun 03 2026 03:29 PM, the price-to-book (PB) ratio for Medico Remedies Ltd share is 9.09.

How to Buy Medico Remedies Ltd Share?

Answer Field

You can trade in Medico Remedies Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Medico Remedies Ltd Share on Bajaj Broking App?

Answer Field

To buy Medico Remedies Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Medico Remedies Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|